Zoë-CM2® Culture Module
The Zoë-CM2® Culture Module combines instruments, consumables, and software, enabling unprecedented insights into human biology across a variety of organs.
Receive your quote directly from the manufacturer.
The Human Emulation System is a complete Organ-on-a-Chip solution that combines instruments, consumables, and software, enabling unprecedented insights into human biology across a variety of organs. At the heart of the Human Emulation System is the Zoë-CM2® Culture Module, which automates the precise microphysiological conditions needed to culture up to 12 Emulate Organ-Chips. It enables researchers to build a wide variety of organ models for myriad applications—from disease modeling, to target validation, to drug from disease modeling, to target validation, to drug candidate safety and efficacy evaluation. The Human Emulation System can be paired with any Organ-Chip offering from Emulate, including Emulate's BioKits to build a validated organ model with pre-qualified biology, or one of Emulate's Basic Research Kits to design your own organ model using Chip-S1 or Chip-R1 consumables.
Accelerating animal-free drug pipelines with organ-on-a-chip technology
June 23, 2025 – 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Animal models within the realms of therapeutic testing have limited predictive value, which poses a significant challenge and raises concerns about their broader use in basic research. Therefore, welcoming new approaches to produce human-relevant data is essential for improving translational success and advancing our understanding of human biology.
Join Emulate’s Dr. Lorna Ewart, Chief Scientific Officer and Dr. Daniel Levner, Chief Technology Officer, as they share the predictive power of organ-on-a-chip. Discover how this next-generation technology can be used for toxicology testing to support your drug development efforts by seamlessly integrating into your existing workflow and project a quantifiable ROI from faster data.
Key learning objectives
- Explore the latest global initiatives encouraging reduced reliance on animal testing and their impact on drug development strategies and regulatory submissions.
- Discover key milestones in Emulate’s collaborations with regulation agencies to establish organ-on-a-chip technology.
- Learn how Emulate’s current and upcoming platforms align with evolving regulatory expectations worldwide and help future-proof your drug development pipeline against shifting standards in animal testing.
Who should attend?
- Executives, lab managers, scientists and end users working in the pharma and biopharma industry
- Academics such as professors, assistant professors and post-docs
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Could organ-on-a-chip models help replace animal drug testing?
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap
